{"id":251606,"date":"2021-06-12T00:00:00","date_gmt":"2021-06-12T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/epidcg0105-biopharma-chronic-fatigue-syndrome-epidemiology-europe\/"},"modified":"2026-04-23T11:34:08","modified_gmt":"2026-04-23T11:34:08","slug":"epidcg0105-biopharma-chronic-fatigue-syndrome-epidemiology-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/epidcg0105-biopharma-chronic-fatigue-syndrome-epidemiology-europe\/","title":{"rendered":"Chronic Fatigue Syndrome &#8211; Epidemiology &#8211; Europe"},"content":{"rendered":"<p><!--[if gte mso 9]><xml>\n <o:OfficeDocumentSettings>\n  <o:AllowPNG\/>\n <\/o:OfficeDocumentSettings>\n<\/xml><![endif]--><!--[if gte mso 9]><xml>\n <w:WordDocument>\n  <w:View>Normal<\/w:View>\n  <w:Zoom>0<\/w:Zoom>\n  <w:TrackMoves\/>\n  <w:TrackFormatting\/>\n  <w:PunctuationKerning\/>\n  <w:ValidateAgainstSchemas\/>\n  <w:SaveIfXMLInvalid>false<\/w:SaveIfXMLInvalid>\n  <w:IgnoreMixedContent>false<\/w:IgnoreMixedContent>\n  <w:AlwaysShowPlaceholderText>false<\/w:AlwaysShowPlaceholderText>\n  <w:DoNotPromoteQF\/>\n  <w:LidThemeOther>EN-GB<\/w:LidThemeOther>\n  <w:LidThemeAsian>X-NONE<\/w:LidThemeAsian>\n  <w:LidThemeComplexScript>X-NONE<\/w:LidThemeComplexScript>\n  <w:Compatibility>\n   <w:BreakWrappedTables\/>\n   <w:SnapToGridInCell\/>\n   <w:WrapTextWithPunct\/>\n   <w:UseAsianBreakRules\/>\n   <w:DontGrowAutofit\/>\n   <w:SplitPgBreakAndParaMark\/>\n   <w:EnableOpenTypeKerning\/>\n   <w:DontFlipMirrorIndents\/>\n   <w:OverrideTableStyleHps\/>\n  <\/w:Compatibility>\n  <m:mathPr>\n   <m:mathFont m:val=\"Cambria Math\"\/>\n   <m:brkBin m:val=\"before\"\/>\n   <m:brkBinSub m:val=\"--\"\/>\n   <m:smallFrac m:val=\"off\"\/>\n   <m:dispDef\/>\n   <m:lMargin m:val=\"0\"\/>\n   <m:rMargin m:val=\"0\"\/>\n   <m:defJc m:val=\"centerGroup\"\/>\n   <m:wrapIndent m:val=\"1440\"\/>\n   <m:intLim m:val=\"subSup\"\/>\n   <m:naryLim m:val=\"undOvr\"\/>\n  <\/m:mathPr><\/w:WordDocument>\n<\/xml><![endif]--><\/p>\n<p>Clarivate Epidemiology\u2019s coverage of chronic fatigue syndrome (<abbr title=\"chronic fatigue syndrome\">CFS<\/abbr>) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of <abbr title=\"chronic fatigue syndrome\">CFS<\/abbr> for each country, as well as annualized case counts projected to the national population.<\/p>\n<p>Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and other key European countries covered.<\/p>\n<p>Clarivate Epidemiology\u2019s <abbr title=\"chronic fatigue syndrome\">CFS<\/abbr> forecast will answer the following questions:<\/p>\n<ul class=\"round-bullets\">\n<li>How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of <abbr title=\"chronic fatigue syndrome\">CFS<\/abbr> over the forecast period?<\/li>\n<\/ul>\n<p>All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to <abbr title=\"multiple sclerosis\">MS<\/abbr> Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.<\/p>\n<p>In total, Clarivate Epidemiology forecasts five <abbr title=\"chronic fatigue syndrome\">CFS<\/abbr> patient populations:<\/p>\n<ul class=\"round-bullets\">\n<li>Diagnosed prevalent cases.<\/li>\n<li>Diagnosed prevalent cases with fibromyalgia.<\/li>\n<li>Total prevalent cases with pain in two or more joints.<\/li>\n<li>Total prevalent cases.<\/li>\n<li>Total prevalent cases with muscle pain.<\/li>\n<\/ul>\n<p>Note: Coverage may vary by country.<\/p>\n","protected":false},"template":"","class_list":["post-251606","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-psychiatry","biopharma-product-epidemiology","biopharma-geography-europe","biopharma-date-950"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":10,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251606\/revisions"}],"predecessor-version":[{"id":576398,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/251606\/revisions\/576398"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=251606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}